Imipenem is as emisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Its effectiveness is enhanced when it is administered in combination with CILASTATIN, a renal dipeptidase inhibitor.
Qin, Yun; Bai, Zhiquan; Liu, Xicheng; Wu, Jianjun; Tang, Hong. A process for preparing imipenem and its intermediates. Assignee Chongqing Tiandi Pharmaceutical Co., Ltd., Peop. Rep. China. CN 108623598. (2018).
Gnanaprakasam, Andrew; Ganapathy, Veeramani; Sekar, Jeyaraj; Arulmoli, Thangavel. A process for the preparation of pure crystalline imipenem monohydrate. Assignee Sequent Anti Biotics Limited, India. IN 2010CH03462. (2012).
Ren, Peng; Chen, Chonghong; Zhu, Xizong; Mo, Shenghua; Ou, Peng; Liu, Shaoxiong; Li, Hao; Huang, Huayong; Guo, Jingning; Zhang, Yanjun; Wang, Xiaohua; Shang, Wanli. Method for preparation of Imipenem. Assignee Shenzhen Haibin Pharmaceutical Co., Ltd., Peop. Rep. China. CN 101921275. (2010).
Bai, Hua; Zheng, Yuguo; Yang, Zhiqing; Meng, Qiang; Zheng, Renchao; Shen, Yinchu. Method for synthesizing (5R,6S)-6-[(1R)-hydroxyethyl]-1-azabicyclo[3.2.0]heptane-3,7-dione-2-carboxylic acid esters and imipenem. Assignee Zhejiang Hisun Pharmaceutical Co., Ltd., Peop. Rep. China; Zhejiang University of Technology. CN 101735219. (2010).
